Paul, ChristineD'Este, CatherineRyan, AnnikaJayakody, AmandaAttia, JohnOldmeadow, ChristopherKerr, ErinHenskens, FransGrady, AliceLevi, Christopher2020-03-202020-03-201911-2092http://hdl.handle.net/1885/202394Background: Intravenous thrombolysis is one of few evidence-based treatments for acute stroke. Treatment uptake is low outside major stroke care centres. There is a need for greater understanding of barriers encountered by clinicians when seeking to increase thrombolysis rates.This work is related to a National Health and Medical Research Council (NHMRC) partnership grant (ID569328) and is part-funded by a Translating Research Into Practice fellowship, with collaborative funding from Boehringer Ingelheim and in-kind support from the Agency for Clinical Innovation Stroke Care Network/Stroke Services NSW, Victorian Stroke Clinical Network, National Stroke Foundation and NSW Cardiovascular Research Network–National Heart Foundation, Hunter Medical Research Institute and the University of Newcastle. Christine Paul is supported by an NHMRC Career Development Fellowship (APP1061335).application/pdfen-AU© The Author(s) 2019http://www.creativecommons.org/licenses/by-nc/4.0/201910.1177/20503121198656562019-11-25Creative Commons Non Commercial CC BY-NC